3D7 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Willow Biosciences Inc

Watchlist Manager

Watchlist

Price: 0.0955 EUR -21.72% Market Closed

Market Cap: €13.7m

	Willow Biosciences Inc F:3D7	CA
V	Vinci SA OTC:VCISY	FR
	Coveo Solutions Inc TSX:CVO	CA
S	Societe BIC SA DUS:BIF	FR
O	Oracle Corp DUS:ORC	US
K	Kering SA DUS:PPX	FR
	Telekom Austria AG F:TA1	AT
U	UniCredit SpA OTC:UNCFF	IT
O	Olympia Financial Group Inc TSX:OLY	CA
T	Tile Shop Holdings Inc F:2TS	US

Profitability Summary

Willow Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-49%

Negative 3Y Average Operating Margin

-754%

Operating Margin is Increasing

-1 809% > -49%

Negative Net Margin

-65%

Negative 3Y Average Net Margin

-737%

Net Margin is Increasing

-1 760% > -65%

Negative Free Cash Flow Margin

-34%

Negative 3Y Average Free Cash Flow Margin

-631%

Free Cash Flow Margin is Increasing

-1 584% > -34%

Negative ROE

-971%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-361%

ROIC is Increasing

-475% > -144%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.